System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Tawesak Tanwandee is an expert in Hepatology at Siriraj Hospital (Thailand). As of October 2026, ScienceLeadR ranks Tawesak Tanwandee in the top 1% of experts worldwide for Hepatitis, and in the top 1% of experts in Thailand for Liver Neoplasms. Tawesak Tanwandee has authored 208 publications, the most recent in 2026, and is an investigator in 22 clinical trials, 2 of them ongoing. SLR score: 1,028 (community average: 125). How the SLR is computed.

LeadR Profile

Tawesak Tanwandee Siriraj Hospital Thailand
1 028 ScienceLeadR Reputation 1028

Unlock

Register Login
Network Map

Hepatology

Subspecialties: Gastroenterology - Oncology - Infectiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2006 - 2026
Source: PubMed

Mahidol University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 208

Citations

Citations: 9 693 1st author: 7 Last author: 40 Unique author: 0

Main journals

Gastroenterology 32
J Hepatol 28
Hepatol Int 26
J Gastroenterol Hepatol 9
J Med Assoc Thai 8

Best Journals

J Hepatol 4
Lancet Gastroenterol Hepatol 3
N Engl J Med 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Hepatocellular carcinoma surveillance in Europe: challenges and lessons from global practice.
PMID 42819713 — carcinoma, hepatocellular, liver, diagnosis		Lancet Reg Health Eur20261
Correction: The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence-assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver disease.
PMID 42637880 — liver diseases, intelligence, liver, artificial intelligence, fatty liver		Hepatol Int20260
BEAT-B Study (Behavior, Aspirations, and Treatment Needs): A Mixed-Methods Study of Patient Values, Preferences, and Barriers to Care Among People Living With Chronic Hepatitis B in South and Southeast Asia.
PMID 42572228 — liver diseases, quality of life, gastroenterology, hepatitis, chronic, therapeutics, hepatitis b, counseling, aspirations, psychological, hepatitis b, chronic, hepatitis		J Gastroenterol Hepatol20262
National guideline for hepatitis B elimination in Thailand: a decentralized health system model for expanding diagnosis and treatment.
PMID 42547747 — liver diseases, carcinoma, hepatocellular, vaccines, diagnosis, therapeutics, hepatitis b, hepatitis		Hepatol Int20260
A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper.
PMID 42533257 — liver diseases, acute-on-chronic liver failure, multiple chronic conditions, critical care, liver, therapeutics, liver failure		Hepatol Int20261

Clinical Studies 22

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5 Study Chair: 1 Study Director: 1

By phase:

N/A 7
Phase 4 5
Phase 3 4
Phase 2 3
Phase 1 2
Phase 1/Phase 2 1

By status:

Completed 15
Unknown 3
Terminated 2
Enrolling by invitation 1
Recruiting 1

By type:

Interventional 16
Observational 6

By Monocentric/Multicentric:

monocentric 10
multicentric2to4 2
multicentric5to9 1
multicentricup10 9

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
STOP HCC GAAD APAC Thailand
NCT07319299 — fetal proteins, carcinoma, hepatocellular, blood, serum, absenteeism, mental recall, vitamins, fibrosis, tomography, magnetic resonance imaging, liver, vitamin k, alpha-fetoproteins, infections, carcinoma		N/AEnrolling by invitation2025
Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis
NCT06277882 — liver diseases, injections, vaccines, liver cirrhosis, fibrosis, liver, vaccination, viruses, hepatitis a, injections, intramuscular, infections, hepatitis		Phase 4Recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS